PRECISION ONCOLOGY CONNECT is an international group of experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers, and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients
Previously known as NTRK CONNECT, this site was updated to PRECISION ONCOLOGY CONNECT in January 2023
PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from AstraZeneca, Amoy Diagnostics, Bayer and Pierre Fabre.
